Cephalon Inc.

cephalon inc. - All News and Analysis

• Pharma Roundup: Cephalon Hikes Provigil Prices, Icahn Eyes Amylin, and More

  BNET - 2008-11-18

  Cephalon hopes Provigil price hikes now will keep its customers later. Icahn wants Amylin, perhaps. Johnson & Johnson pays for Duragesic death. Anti-depressants may be equivalent. by John Maas

  Tags: Cephalon Inc., Icahn, John Maas, Johnson & Johnson, Provigil, Patches, Security

• Cephalon: Damn the Torpedoes! We're Raising Prices!

  BNET - 2008-11-18

  A corporate strategy question for you about Cephalon: Your industry is unpopular because of its rising prices. Your company's marketing is under the control of the U.S. Department of Justice due to illegal off-label sales. One of your best-known brands is already facing generic competition, and one of your best-selling...

  Tags: Brand, Cephalon Inc., Provigil, Nuvigil, Provigil Sale, Sales Strategy, Branding, Sales Force Management, Sales, Marketing, Jim Edwards

• Cephalon Inc. Q3 2008 Earnings Conference Call Transcript

  Seeking Alpha - 2008-10-28

  Question-and-Answer SessionThank you. [Operator Instructions]. We will take our first question from David Buck with Buckingham Research. David Buck - Buckingham Research Group Yes, thanks for taking the question. Just a couple. First on 2009, Frank, you mentioned the potential for promotional claims for individual. Is there potential... the...

  Tags: Opportunity, Executive Vice President, Call Transcript, Officer, Cephalon Inc., Enrollment, Earnings, Seeking Alpha

• Acusphere Announces Signing of a Definitive Agreement with Cephalon

  - 2008-10-25

  WATERTOWN, Mass. -- Acusphere, Inc. (NASDAQ:ACUS) today announced the signing of a definitive agreement with Cephalon, Inc. to provide $20 million in upfront financing by purchasing a $15 million senior secured convertible note and by paying a $5 million upfront fee for an exclusive worldwide license to AI-525, a preclinical-stage...

  Tags: agreement, Cephalon Inc., Company, FDA, FINANCE, Government, Nasdaq Stock Market Inc., Readers

• Pharma Roundup: Pfizer and Glaxo Confirm Layoffs, Disclosure Mandated for Cephalon, and More

  - 2008-10-01

  Pharma Roundup: Pfizer and Glaxo Confirm Layoffs, Disclosure Mandated for Cephalon, and MoreRE: Pharma Roundup: Pfizer and Glaxo Confirm Layoffs, Disclosure Mandated for Cephalon, and Morethe figures are very stuning and i was shocked after having look at the figures of Johnson & johnson but one thing which was disturbing...

  Tags: Workforce management, Cephalon Inc., Glaxo, Roundup, Pfizer Inc., pharmaceutical company, layoff

• Pharma Roundup: Pfizer and Glaxo Confirm Layoffs, Disclosure Mandated for Cephalon, and More

  BNET - 2008-09-30

  Glaxo and Pfizer confirm R&D layoffs; Cephalon ordered to reveal the doctors it pays; Prasugrel delay not all that bad for Lilly; pharma sales reps unpopular with docs by John Maas

  Tags: Layoff, Pfizer Inc., Cephalon Inc., Research & Development, Workforce Management, Marketing Research, Business Operations, Human Resources, Marketing, John Maas

• "Pain Is Pain": Cephalon's Marketing Comes Under DOJ Control

  BNET - 2008-09-30

  Cephalon agreed yesterday to a $444 million settlement with the Department of Justice that will control its marketing of Actiq, Provigil and Gabitril. (Scroll to the bottom of this page if you want to read the prosecutors' documents describing the scale of wrongdoing at the company.) The...

  Tags: CIA, Cephalon Inc., U.S. Department Of Justice, Marketing Research, Marketing, Jim Edwards

• Behind Cephalon's Numbers: a Big Cancer Bet and Signs of Skepticism

  BNET - 2008-09-16

  The FDA delivered to Cephalon a letter yesterday saying it would not approve expanded indications for its pain drug Fentora until the company gave it more information on how it would prevent the drug from being abused. Even though the Fentora situation is fixable, it's just the sort of headache...

  Tags: Patient, Cephalon Inc., Revenue Picture, Provigil, Nuvigil, Amrix, Treanda, Sales Strategy, Operational Accounting, Sales, Finance, Jim Edwards

• Analyst Reports for Shanda Interactive Entertainment Limited, Costco Wholesale Corporation, Cephalon Inc., and Zumiez Inc.

  - 2008-09-04

  MaybachFinancial.com is one of the fastest growing independent and unbiased research firms in the world. Through our numerous partnerships with many of the top investment minds in the world, we provide research on companies making a move in the markets. Investors seeking genuine analyst opinions on their investments for Shanda...

  Tags: analyst, Cephalon Inc., Costco Wholesale Corp., FINANCE, Investment, Nasdaq Stock Market Inc., Zumiez Inc.

• SL Pharma Wins SFDA Approval for New Drug and a Clinical Trial

  Seeking Alpha - 2008-08-29

  ChinaBio Today submits: Beijing SL Pharmaceutical Co. Ltd. (SZSE: 002038) received SFDA approval to begin producing a hepatitis drug and a second SFDA authorization to begin clinical trials of drug for male infertility. Adefovir dipivoxil, the drug newly approved for marketing, is aimed at hepatitis B. It is currently...

  Tags: Biotech, China, Cephalon Inc.

• Cephalon, Inc. Q2 2008 Earnings Call

  Seeking Alpha - 2008-07-29

  Question-and-Answer SessionThe question and answer session will be conducted electronically. [Operator Instructions]. We will pause just a moment. We'll take our first question from Jim Birchenough with Lehman Brothers. Jim Birchenough - Lehman Brothers Hi, guys. Congratulations on the quarter. I want to start-off with a big picture question...

  Tags: Cephalon Inc.

• Zacks Analyst Blog Highlights: Eurand NV, Cephalon, GlaxoSmithKline, Kodiak Oil & Gas and Devon Energy

  - 2008-05-19

  CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Eurand NV (Nasdaq: EURX), Cephalon (Nasdaq: CEPH), GlaxoSmithKline (NYSE: GSK), Kodiak...

  Tags: blog, Cephalon Inc., GlaxoSmithKline Plc., stock

• Cephalon, Inc. Q1 2008 Earnings Call Transcript

  Seeking Alpha - 2008-05-02

  Question-and-Answer SessionThank you. The question and answer session will be conducted electronically. [Operator Instructions]. And we'll take our first question from David Buck with Buckingham Investments. David Buck - Buckingham Investments Yes, thanks for taking the question. First, for Frank on the upcoming panel for FENTORA, your comment about...

  Tags: Cephalon Inc.

• The Franklin Institute Receives Record $4 Million Gift from Biopharmaceutical Leader, Cephalon

  - 2008-04-25

  Gift to Support Creation of Brain Exhibit

  Tags: Cephalon Inc.

• Zacks Analyst Blog Highlights: Alkermes, Eli Lilly, Johnson & Johnson, Cephalon and GlaxoSmithKline

  - 2008-03-31

  CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Alkermes, Inc. (Nasdaq: ALKS), Eli Lilly (NYSE: LLY), Johnson & Johnson...

  Tags: Alkermes Inc., analyst, blog, Cephalon Inc., Eli Lilly & Co., FINANCE, GlaxoSmithKline Plc., Investment, Johnson & Johnson, Nasdaq Stock Market Inc., New York Stock Exchange, newsletter, stock

• Cephalon Receives FDA Approval for TREANDA, a Novel Chemotherapy for Chronic Lymphocytic Leukemia

  - 2008-03-20

  First New Agent for CLL Patients Approved by the FDA Since 2001

  Tags: Cephalon Inc.

• Zacks Analyst Blog Highlights: Eurand NV, Cephalon and GlaxoSmithKline

  - 2008-03-11

  CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Eurand NV (Nasdaq: EURX), Cephalon, Inc. (Nasdaq: CEPH) and GlaxoSmithKline (NYSE:...

  Tags: blog, Cephalon Inc., GlaxoSmithKline Plc., stock

• FTC accuses Cephalon over Provigil in patent case

  - 2008-02-14

  The Federal Trade Commission filed a lawsuit yesterday against Cephalon Inc. over deals it struck with four makers of generic drugs that had challenged the patent on Cephalon's biggest drug, Provigil. The agreements, which the FTC said were worth more than $200 million, would prevent four companies - Teva Pharmaceutical...

  Tags: Cephalon Inc., FTC, Provigil, SALES

• Cephalon, Inc. Q4 2007 Earnings Call Transcript

  Seeking Alpha - 2008-02-12

  Question-and-Answer Session[Operator Instructions]. Our first question will come Greg Gilbert with Merrill Lynch. Greg Gilbert - Merrill Lynch Thanks. I have a couple. First for Kevin. Can you help us with what level of TREANDA expense you filed in for '08, if possible broken down between launch related versus...

  Tags: Cephalon Inc.

• Zacks Analyst Blog Highlights: U.S. Cellular, Telephone and Data Systems, Eurand NV and Cephalon

  - 2008-01-14

  CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: U.S. Cellular (NYSE: USM), Telephone and Data Systems (NYSE: TDI), Eurand...

  Tags: blog, Cephalon Inc., phone, stock

• Incorporated: 1987
• CEO: Dr. Frank Baldino Jr., Ph.
• Employees: 2,796